Follow
Jo Lynne Rokita
Jo Lynne Rokita
Children's Hospital of Philadelphia
Verified email at email.chop.edu - Homepage
Title
Cited by
Cited by
Year
Integrated proteogenomic characterization across major histological types of pediatric brain cancer
F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ...
Cell 183 (7), 1962-1985. e31, 2020
1962020
Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma
KR Bosse, P Raman, Z Zhu, M Lane, D Martinez, S Heitzeneder, KS Rathi, ...
Cancer cell 32 (3), 295-309. e12, 2017
1642017
Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design
JL Rokita, KS Rathi, MF Cardenas, KA Upton, J Jayaseelan, KL Cross, ...
Cell reports 29 (6), 1675-1689. e9, 2019
1482019
Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines
JL Harenza, MA Diamond, RN Adams, MM Song, HL Davidson, LS Hart, ...
Scientific Data 4 (1), 1-9, 2017
1402017
Cross-cohort analysis identifies a TEAD4–MYCN positive feedback loop as the core regulatory element of high-risk neuroblastoma
P Rajbhandari, G Lopez, C Capdevila, B Salvatori, J Yu, ...
Cancer discovery 8 (5), 582-599, 2018
1272018
Telomere maintenance mechanisms define clinical outcome in high-risk neuroblastoma
B Koneru, G Lopez, A Farooqi, KL Conkrite, TH Nguyen, SJ Macha, ...
Cancer research 80 (12), 2663-2675, 2020
682020
ASCL1 is a MYCN-and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry
L Wang, TK Tan, AD Durbin, MW Zimmerman, BJ Abraham, SH Tan, ...
Nature communications 10 (1), 5622, 2019
682019
The pediatric cell atlas: defining the growth phase of human development at single-cell resolution
DM Taylor, BJ Aronow, K Tan, K Bernt, N Salomonis, CS Greene, ...
Developmental cell 49 (1), 10-29, 2019
622019
Epigenomic profiling of neuroblastoma cell lines
K Upton, A Modi, K Patel, NM Kendsersky, KL Conkrite, RT Sussman, ...
Scientific data 7 (1), 116, 2020
612020
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
J Voeller, AK Erbe, J Slowinski, K Rasmussen, PM Carlson, A Hoefges, ...
Journal for ImmunoTherapy of Cancer 7, 1-13, 2019
582019
YAP1 mediates resistance to MEK1/2 inhibition in neuroblastomas with hyperactivated RAS signaling
GE Coggins, A Farrel, KS Rathi, CM Hayes, L Scolaro, JL Rokita, ...
Cancer research 79 (24), 6204-6214, 2019
552019
Inhibition of monoacylglycerol lipase reduces nicotine withdrawal
PP Muldoon, J Chen, JL Harenza, RA Abdullah, LJ Sim‐Selley, ...
British journal of pharmacology 172 (3), 869-882, 2015
462015
Genetic variation within the Chrna7 gene modulates nicotine reward‐like phenotypes in mice
JL Harenza, PP Muldoon, M De Biasi, MI Damaj, MF Miles
Genes, Brain and Behavior 13 (2), 213-225, 2014
462014
The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence
KJ Jackson, X Chen, MF Miles, JL Harenza, MI Damaj
Neuropsychopharmacology 36 (11), 2339-2348, 2011
432011
The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies
PP Muldoon, KJ Jackson, E Perez, JL Harenza, S Molas, B Rais, H Anwar, ...
British Journal of Pharmacology 171 (16), 3845-3857, 2014
412014
Germline 16p11. 2 microdeletion predisposes to neuroblastoma
LE Egolf, Z Vaksman, G Lopez, JL Rokita, A Modi, PV Basta, ...
The American Journal of Human Genetics 105 (3), 658-668, 2019
372019
International comparison of enumeration-based quantification of DNA copy-concentration using flow cytometric counting and digital polymerase chain reaction
HB Yoo, SR Park, L Dong, J Wang, Z Sui, J Pavšič, M Milavec, ...
Analytical chemistry 88 (24), 12169-12176, 2016
372016
Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
MT Dang, MV Gonzalez, KS Gaonkar, KS Rathi, P Young, S Arif, L Zhai, ...
Cell reports 34 (13), 2021
322021
Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003
C Kline, P Jain, L Kilburn, ER Bonner, N Gupta, JR Crawford, A Banerjee, ...
Clinical Cancer Research 28 (18), 3965-3978, 2022
312022
Pediatric high-grade glioma resources from the Children’s Brain Tumor Tissue Consortium
H Ijaz, M Koptyra, KS Gaonkar, JL Rokita, VP Baubet, L Tauhid, Y Zhu, ...
Neuro-oncology 22 (1), 163-165, 2020
312020
The system can't perform the operation now. Try again later.
Articles 1–20